Notícias e Atividades da Atavistik Bio

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da Atavistik Bio

• Bryan Stuart, Chief Executive Officer and Director
• Jeff Goater, Director
• Shaq Vayda, Director

Recentes movimentos de executivos em Atavistik Bio

• Mohammad Hirmand, ingressou na Companhia como Director  (Notícia publicada em 26 de setembro de 2024).
• Paul Bruno, ingressou na Companhia como Chief Business Officer  (Notícia publicada em 13 de agosto de 2024).

Criar um alerta
para seguir os movimentos de executivos da Atavistik Bio.

Atavistik Bio possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Genus (Reino Unido).

Popular M&A news in Biotecnologia

• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..
• Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
• Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Atavistik Bio

• Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics - Atavistik Bio
• Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - Atavistik Bio
• Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor - Atavistik Bio
• Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors - Atavistik Bio
• Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer - Atavistik Bio
• Atavistik Bio Raises Additional $40 Million to Advance Precision Allosteric Small Molecule Therapeutics - Atavistik Bio
• Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer - Atavistik Bio
• The Search to Unlock Protein-Metabolite Interactions: An interview with Jared Rutter, Ph.D. and Kevin Hicks, Ph.D. About Atavistik Bio’s Foundational Technology and the Inspiration - Atavistik Bio
• Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform - Atavistik Bio
• Atavistik Bio Announces Collaboration with Plex Research to Enrich the Informatics Capabilities of its AMPS Platform and Accelerate the Discovery of Novel Small Molecule Therapeutics - Atavistik Bio
• View more press releases Close

Redes sociais sobre Atavistik Bio

• Atavistik Bio na Wikipedia, Google News e Yahoo Finance
• Atavistik Bio na LinkedIn, Twitter e YouTube